Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U. Mauritz C, et al. Among authors: katsirntaki k. Circulation. 2008 Jul 29;118(5):507-17. doi: 10.1161/CIRCULATIONAHA.108.778795. Epub 2008 Jul 14. Circulation. 2008. PMID: 18625890
Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.
Schmeckebier S, Mauritz C, Katsirntaki K, Sgodda M, Puppe V, Duerr J, Schubert SC, Schmiedl A, Lin Q, Paleček J, Draeger G, Ochs M, Zenke M, Cantz T, Mall MA, Martin U. Schmeckebier S, et al. Among authors: katsirntaki k. Tissue Eng Part A. 2013 Apr;19(7-8):938-51. doi: 10.1089/ten.tea.2012.0066. Epub 2013 Jan 15. Tissue Eng Part A. 2013. PMID: 23176317
Bronchoalveolar sublineage specification of pluripotent stem cells: effect of dexamethasone plus cAMP-elevating agents and keratinocyte growth factor.
Katsirntaki K, Mauritz C, Olmer R, Schmeckebier S, Sgodda M, Puppe V, Eggenschwiler R, Duerr J, Schubert SC, Schmiedl A, Ochs M, Cantz T, Salwig I, Szibor M, Braun T, Rathert C, Martens A, Mall MA, Martin U. Katsirntaki K, et al. Tissue Eng Part A. 2015 Feb;21(3-4):669-82. doi: 10.1089/ten.TEA.2014.0097. Epub 2014 Dec 1. Tissue Eng Part A. 2015. PMID: 25316003
Back signaling of HLA class I molecules and T/NK cell receptor ligands in epithelial cells reflects the rejection-specific microenvironment in renal allograft biopsies.
Egelkamp J, Chichelnitskiy E, Kühne JF, Wandrer F, Daemen K, Keil J, Bräsen JH, Schmitz J, Bellmàs-Sanz R, Iordanidis S, Katsirntaki K, Hake K, Akhdar A, Neudörfl C, Haller H, Blume C, Falk CS. Egelkamp J, et al. Among authors: katsirntaki k. Am J Transplant. 2019 Oct;19(10):2692-2704. doi: 10.1111/ajt.15417. Epub 2019 May 28. Am J Transplant. 2019. PMID: 31062482 Free article.
Citrate-Coated Iron Oxide Nanoparticles Facilitate Endothelialization of Left Ventricular Assist Device Impeller for Improved Antithrombogenicity.
Haritz JL, Pflaum M, Güntner HJ, Katsirntaki K, Hegermann J, Hehnen F, Lommel M, Kertzscher U, Arens J, Haverich A, Ruhparwar A, Wiegmann B. Haritz JL, et al. Among authors: katsirntaki k. Adv Sci (Weinh). 2024 Dec 20:e2408976. doi: 10.1002/advs.202408976. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39707689